Age-related macular degeneration (AMD) is the leading cause of blindness in people over 60 and accounts for 90% of new cases of blindness in Canada. Early diagnosis is critical to preserve a patient’s vision, unfortunately, studies show that up to 25% of people over 60 show early signs of AMD that their eye doctor has not detected.
At Entangled Vision, we use technology from the world of quantum information to detect AMD before vision loss begins. Our test costs patients only $15, can detect AMD earlier than the standard-of-care, and can be upgraded to test for other disorders through software updates alone. Clinics stand to capture $25 billion in revenue by treating currently undiagnosed AMD patients and can treat more patients in a day by automating AMD screening.
Founder and CEO
Innovation Factory’s Synapse Competition is Ontario’s premier life science pitch competition, dedicated to fostering innovation in the life science sector.
March 26, 2025 | 4:00pm – 8:00pm EDT